RecruitingNot ApplicableNCT03629418

Targeted Blood-pressure Management and Acute Kidney Injury After Coronary Artery Bypass Surgery

Impact of Targeted Blood-pressure Management on Incidence of Acute Kidney Injury After Off-pump Coronary Artery Bypass Surgery: A Randomized Controlled Trial


Sponsor

Peking University First Hospital

Enrollment

612 participants

Start Date

Aug 14, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

Acute renal injury (AKI) is a common complication after cardiac surgery and is associated with worse outcomes. It is now realized that intraoperative hypotension is an important risk factor for the development of AKI. In a recent randomized controlled trial of patients undergoing major noncardiac surgery, intraoperative individualized blood-pressure management reduced the incidence of postoperative organ dysfunction. The investigators hypothesize that, for patients undergoing off-pump CABG, targeted blood-pressure management during surgery may also reduce the incidence of postoperative AKI.


Eligibility

Min Age: 50 Years

Inclusion Criteria2

  • Age ≥ 50 years;
  • Scheduled to undergo off-pump CABG surgery.

Exclusion Criteria7

  • Refuse to participate;
  • Untreated or uncontrolled severe hypertension (systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥110 mmHg);
  • Chronic kidney disease with a glomerular filtration rate < 30 ml/min/1.73 m2 or end-stage renal disease requiring renal-replacement therapy;
  • Inability to communicate during the preoperative period because of coma, profound dementia, language barrier, or end-stage disease;
  • Requirement of vasopressors/inotropics to maintain blood pressure before surgery;
  • Second or emergency surgery;
  • Expected survival of less than 24 hours.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTargeted blood-pressure management

Prophylactic norepinephrine infusion is started before anesthetic induction and maintained throughout surgery. The target is to maintain systolic blood pressure at 110 mmHg or higher.

DRUGRoutine blood-pressure management

Phenylephrine (25-50 ug) is injected or vasopressors is infused only when necessary. The target is to maintain systolic blood pressure at 90 mmHg or higher during surgery.


Locations(1)

Beijing University First Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03629418


Related Trials